Shopping Cart 0
Cart Subtotal
USD 0

Apotex Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 750

Details

Summary

Apotex Inc (Apotex) produces and markets a wide range of generic pharmaceuticals. It also undertakes the research, development, manufacture and distribution of non-prescription and private label medicines, fine chemicals and disposable plastics for medical use. The company has research and development (R&D) facilities in Richmond Hill, Toronto, Etobicoke, Brantford, Windsor and Winnipeg. It offers its products to patients, healthcare providers and payers, governments and other pharmaceutical manufacturers. It operates through subsidiaries, joint ventures and licensing agreements across Americas, Europe, the Middle East, Africa and Asia-Pacific. Apotex is headquartered in Toronto, Ontario, Canada.

Apotex Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Apotex Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Apotex Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Apotex Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Apotex Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Apotex Inc, Medical Devices Deals, 2012 to YTD 2018 10

Apotex Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Apotex Inc, Pharmaceuticals & Healthcare, Deal Details 12

Private Equity 12

Charterhouse Capital Partners Acquires Doc Generici For USD 424 Million 12

Merger 14

Apotex to Merge with Strides Shasun 14

Licensing Agreements 15

Panacea Biotec Expands Licensing Agreement with Apotex 15

Cangene Enters Into Licensing Agreement With Apotex For Biotech Drugs 16

Stada Arzneimittel Enters Into License Agreement With Apotex For Filgrastim 17

Asset Transactions 19

Aurobindo Pharma to Acquire Generics Business of Apotex 19

Acquisition 20

Apotex Acquires Aveva Drug Delivery Systems From Nitto Denko 20

Apotex Inc-Key Competitors 21

Apotex Inc-Key Employees 22

Apotex Inc-Locations And Subsidiaries 23

Head Office 23

Other Locations & Subsidiaries 23

Recent Developments 25

Government and Public Interest 25

Mar 08, 2018: Advisory-Chipped pills in additional packages of Alysena 21 and 28 birth control pills 25

Other Significant Developments 26

Mar 08, 2017: Apotex Announces USD 184 Million Investment to Grow U.S. Manufacturing Presence; Expansion Plan Comprises Company's Largest Investment in the United States 26

Appendix 27

Methodology 27

About GlobalData 27

Contact Us 27

Disclaimer 27


List Of Figure

List of Figures

Apotex Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Apotex Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Apotex Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Apotex Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Apotex Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Apotex Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Apotex Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Apotex Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Apotex Inc, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

Apotex Inc, Pharmaceuticals & Healthcare, Key Facts 2

Apotex Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Apotex Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Apotex Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Apotex Inc, Deals By Therapy Area, 2012 to YTD 2018 8

Apotex Inc, Medical Devices Deals, 2012 to YTD 2018 10

Apotex Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Charterhouse Capital Partners Acquires Doc Generici For USD 424 Million 12

Apotex to Merge with Strides Shasun 14

Panacea Biotec Expands Licensing Agreement with Apotex 15

Cangene Enters Into Licensing Agreement With Apotex For Biotech Drugs 16

Stada Arzneimittel Enters Into License Agreement With Apotex For Filgrastim 17

Aurobindo Pharma to Acquire Generics Business of Apotex 19

Apotex Acquires Aveva Drug Delivery Systems From Nitto Denko 20

Apotex Inc, Key Competitors 21

Apotex Inc, Key Employees 22

Apotex Inc, Subsidiaries 23

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Company Profile

Company Profile Title

Summary

Apotex Inc (Apotex) produces and markets a wide range of generic pharmaceuticals. It also undertakes the research, development, manufacture and distribution of non-prescription and private label medicines, fine chemicals and disposable plastics for medical use. The company has research and development (R&D) facilities in Richmond Hill, Toronto, Etobicoke, Brantford, Windsor and Winnipeg. It offers its products to patients, healthcare providers and payers, governments and other pharmaceutical manufacturers. It operates through subsidiaries, joint ventures and licensing agreements across Americas, Europe, the Middle East, Africa and Asia-Pacific. Apotex is headquartered in Toronto, Ontario, Canada.

Apotex Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Apotex Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Apotex Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Apotex Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Apotex Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Apotex Inc, Medical Devices Deals, 2012 to YTD 2018 10

Apotex Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Apotex Inc, Pharmaceuticals & Healthcare, Deal Details 12

Private Equity 12

Charterhouse Capital Partners Acquires Doc Generici For USD 424 Million 12

Merger 14

Apotex to Merge with Strides Shasun 14

Licensing Agreements 15

Panacea Biotec Expands Licensing Agreement with Apotex 15

Cangene Enters Into Licensing Agreement With Apotex For Biotech Drugs 16

Stada Arzneimittel Enters Into License Agreement With Apotex For Filgrastim 17

Asset Transactions 19

Aurobindo Pharma to Acquire Generics Business of Apotex 19

Acquisition 20

Apotex Acquires Aveva Drug Delivery Systems From Nitto Denko 20

Apotex Inc-Key Competitors 21

Apotex Inc-Key Employees 22

Apotex Inc-Locations And Subsidiaries 23

Head Office 23

Other Locations & Subsidiaries 23

Recent Developments 25

Government and Public Interest 25

Mar 08, 2018: Advisory-Chipped pills in additional packages of Alysena 21 and 28 birth control pills 25

Other Significant Developments 26

Mar 08, 2017: Apotex Announces USD 184 Million Investment to Grow U.S. Manufacturing Presence; Expansion Plan Comprises Company's Largest Investment in the United States 26

Appendix 27

Methodology 27

About GlobalData 27

Contact Us 27

Disclaimer 27


List Of Figure

List of Figures

Apotex Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Apotex Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Apotex Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Apotex Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Apotex Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Apotex Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Apotex Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Apotex Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Apotex Inc, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

Apotex Inc, Pharmaceuticals & Healthcare, Key Facts 2

Apotex Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Apotex Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Apotex Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Apotex Inc, Deals By Therapy Area, 2012 to YTD 2018 8

Apotex Inc, Medical Devices Deals, 2012 to YTD 2018 10

Apotex Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Charterhouse Capital Partners Acquires Doc Generici For USD 424 Million 12

Apotex to Merge with Strides Shasun 14

Panacea Biotec Expands Licensing Agreement with Apotex 15

Cangene Enters Into Licensing Agreement With Apotex For Biotech Drugs 16

Stada Arzneimittel Enters Into License Agreement With Apotex For Filgrastim 17

Aurobindo Pharma to Acquire Generics Business of Apotex 19

Apotex Acquires Aveva Drug Delivery Systems From Nitto Denko 20

Apotex Inc, Key Competitors 21

Apotex Inc, Key Employees 22

Apotex Inc, Subsidiaries 23

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS